Drugs / Kava
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06213298 | Jun 2024 → Nov 2027 | anxiety, cancer, depressive disorder | Masonic Cancer Center, University of Minnesota | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kava | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06213298 ↗ |